UCN2 and myopathy: The pathophysiological mechanisms underlying anti‐SRP myopathy likely involves several processes, including the antibody targeting skeletal muscle fibres, resulting in impaired myoblast regeneration, myofiber atrophy, and increased reactive oxygen species [6].